Summary

  • Androgens are usually thought of as male hormones, but the female body naturally produces a small amount of androgens too.
  • Androgen deficiency in women is a controversial concept. Some researchers argue that the condition causes symptoms including lethargy and loss of sexual interest, while other researchers contend that the condition, if it exists, is too poorly understood to safely treat.
  • A woman who chooses to have testosterone replacement therapy needs close and regular monitoring to minimise her risk of side effects.
Androgen deficiency in women is a controversial concept. Androgens are hormones that contribute to growth and reproduction in both men and women. They are usually thought of as male hormones, but the female body also naturally produces a small amount of androgens.

Androgen production in women tapers off with increasing age. By the time a woman is 40 years old, her androgen levels are about half of what they were when she was 20.

Some researchers believe that androgen deficiency in women can cause symptoms that include lethargy and loss of sexual interest. Other researchers believe that the condition, if it exists, is too poorly understood to treat safely.

Androgens explained


Androgens are hormones. Hormones are chemical messengers that communicate with tissues in the body to bring about many different changes. Androgens are usually thought of as male hormones, but the female body naturally produces a small amount of androgens too – on average, about one tenth to one twentieth of the amount produced by the male body.

The most common androgen is testosterone. Dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulphate (DHEAS) and androstenedione are also referred to by some as androgens, although they are actually converted to testosterone and so could be called ‘pre-androgens’.

The ovaries, adrenal glands, fat cells and skin cells make the female body’s supply of androgens. The ovaries convert testosterone into the female hormone oestrogen.

Symptoms of androgen deficiency


Some of the suggested symptoms of androgen deficiency in women may include:
  • lethargy
  • loss of muscle mass and strength
  • loss of libido
  • lack of motivation
  • low emotional state
  • lowered mood.

Causes of androgen deficiency in women


Some of the possible causes of androgen deficiency in women include:
  • ageing – a drop in testosterone naturally occurs in all women over time from about the late teenage years
  • oophorectomy – the surgical removal of the ovaries
  • chemical oophorectomy – ovarian failure caused by certain medication, such as gonadotropin-releasing hormone antagonists, chemotherapy or radiotherapy
  • oestrogen therapy – the combined oral contraceptive pill or oestrogen replacement therapy for managing the symptoms of menopause. Oestrogen, with or without a progestin, suppresses the hormone which stimulates androgen production and when given by mouth, increases the binding protein for testosterone, making less available for biological action
  • hypothalamic amenorrhoea – the loss of menstrual periods in a woman of reproductive age, which could be caused by various factors such as stress, extreme weight loss or extreme exercise. This again lowers the amount of the androgen-stimulating hormone
  • hyperprolactinaemia – overproduction of the pituitary hormone prolactin
  • premature ovarian failure – early menopause (before the age of 40), with various causes
  • adrenal insufficiency – primary or secondary to deficiency of pituitary adrenocorticotropic hormone (ACTH)
  • hypopituitarism – a rare disorder of the pituitary gland.

Diagnosis of androgen deficiency


A full medical check-up is important. The symptoms of androgen deficiency are similar to those of many other conditions, such as hypothyroidism (underactive thyroid), iron deficiency anaemia, autoimmune disease and depression. Your doctor may need to assess you for these conditions.

No specific test for androgen deficiency exists. Many blood and salivary tests for testosterone levels lack accuracy when measuring the low levels present in women, though some sensitive testosterone tests are now available.

Testosterone is difficult to measure for many reasons. For example, the amount circulating in the blood does not reflect the amount active inside body cells. To further complicate matters, a woman’s blood test results can vary depending on when the test is taken, because hormone levels fluctuate, not just throughout the menstrual cycle, but during every day.

Typically, blood to check testosterone levels should be taken in the morning, when testosterone levels are at their peak. For a woman of reproductive age, the test should take place about eight to 20 days after the start of her menstrual period.

Treatment of androgen deficiency in women


Since androgen deficiency in women is still controversial, there is no standard treatment, and no licensed or registered treatment is available for women in Australia.

The most commonly used treatment is testosterone. Most research has been performed in women who have undergone menopause and have had both ovaries removed. Testosterone is available in Australia in the form of a skin cream.

There is no currently approved testosterone product in Australia for use in women. One concern is that the most readily available testosterone products, designed for use in men, contain too much testosterone for the female body. Most Australian specialists familiar with this area recommend treatment with a low-dose testosterone cream (1%) for daily application.

Doctors generally recommend that a woman should not have testosterone replacement therapy, unless she is also having oestrogen replacement therapy (women who still have their uterus also require progesterone treatment). One clinical trial, however, showed that testosterone given without oestrogen is effective, although it also saw a slightly higher rate of breast cancer in the women given testosterone-only treatment.

There have been no long-term studies of testosterone replacement therapy in women, so the long-term health risks and benefits are unknown. The longest study of testosterone use in women followed the women for up to four years. They were postmenopausal and received oestrogen treatment in addition to testosterone.

The main side effects noted in this study using a testosterone patch included skin reactions to the patch and unwanted hair growth. Three cases of breast cancer were detected over the four-year period, which was the expected rate in the age group of women in the study.

Research suggests that some Australian doctors use testosterone replacement therapy to treat a range of women’s health conditions, such as:
  • low libido causing distress (with no other causative factor apparent)
  • iatrogenic (caused by medical treatment) ovarian failure
  • premature menopause

Side effects of testosterone replacement therapy


A woman who chooses to have testosterone replacement therapy needs close and regular monitoring to minimise her risk of side effects. It is also essential to consult a doctor who is knowledgeable in this area, who can give accurate and up-to-date advice, and who can monitor treatment properly.

The risk of side effects depends on many factors, such as the treatment method, the dosage and the duration of therapy. Some of the known side effects of excessive testosterone replacement therapy in women include:
  • masculine physical characteristics, such as facial hair, acne, male-pattern balding, deepened voice, clitoral enlargement (the latter two adverse effects are irreversible). These are extremely unlikely if dosage is monitored appropriately
  • aggressive mood swings
  • sleep apnoea
  • hirsutism – excess hair growth (at the site of testosterone cream application or elsewhere on the face or body)
  • headache.

Some women should never be given testosterone


Testosterone replacement therapy should not be given to women who:
  • are pregnant or planning to become pregnant
  • are of reproductive age, sexually active, but not using adequate contraceptive measures (testosterone can cause serious abnormalities to develop in an unborn baby and termination of pregnancy is likely to be advised if a woman becomes pregnant while using testosterone)
  • are breastfeeding
  • suffer from acne
  • have hirsutism (excessive body or facial hair)
  • suffer from alopecia (hair loss)
  • have steroid-dependent cancers.

Where to get help

  • Your doctor
  • Gynaecologist
  • Endocrinologist
  • Local community health service
  • Specialised women’s health clinic
  • Jean Hailes for Women's Health Tel. 1800 JEAN HAILES (532 642)

Things to remember

  • Androgens are usually thought of as male hormones, but the female body naturally produces a small amount of androgens too.
  • Androgen deficiency in women is a controversial concept. Some researchers argue that the condition causes symptoms including lethargy and loss of sexual interest, while other researchers contend that the condition, if it exists, is too poorly understood to safely treat.
  • A woman who chooses to have testosterone replacement therapy needs close and regular monitoring to minimise her risk of side effects.
References
  • Davis SR, Worsley R 2014, ‘Androgen treatment of postmenopausal women’, J Steroid Biochem Mol Biol. vol. 142, pp. 107-14. More information here.
  • Wierman ME, Basson R, Davis SR. et al., 2006, ‘Androgen therapy in women: an Endocrine Society Clinical Practice guideline’ , The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 3697–710. More information here.
  • The role of testosterone therapy in postmenopausal women: position statement of The North American Menopause Society ’,2005, Menopause, vol. 12, no. 5, pp. 496–511. More information here.
  • Davison S, Bell R, Donath S, et al, 2013, ‘ Androgen levels in adult females: changes with age, menopause, and oophorectomy’ , Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 7, pp. 3847–53. More information here.
  • Nachtigall L, Casson P, Lucas J et al, 2011, ‘Safety and tolerability of testosterone patch therapy for up to four years in surgically menopausal women receiving oral or transdermal oestrogen’, Gynaecological Endocrinology, vol. 27, no. 1, pp. 39-48. More information here.
  • Davis SR, Braunstein GD, 2012, ‘Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women ’, Journal of Sexual Medicine, vol. 9, no. 4, pp. 1134-1148. More information here.

More information

Hormonal system (endocrine)

The following content is displayed as Tabs. Once you have activated a link navigate to the end of the list to view its associated content. The activated link is defined as Active Tab

Content Partner

This page has been produced in consultation with and approved by: Jean Hailes for Women's Health

Last updated: July 2015

Content on this website is provided for education and information purposes only. Information about a therapy, service, product or treatment does not imply endorsement and is not intended to replace advice from your doctor or other registered health professional. Content has been prepared for Victorian residents and wider Australian audiences, and was accurate at the time of publication. Readers should note that, over time, currency and completeness of the information may change. All users are urged to always seek advice from a registered health care professional for diagnosis and answers to their medical questions.